Genotyping and antifungal susceptibility profile of Candida albicans isolated from various clinical samples from tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253599Keywords:
Candida albicans, Genotypes, Antifungal resistance, PCRAbstract
Background: Genotyping Candida albicans helps identify outbreaks, sources, and virulent and drug-resistant strains. PCR can identify Candida albicans isolates as A, B, or C based on transposable group I introns in 25S rDNA. The length of the amplified product divides C. albicans isolates into genotypes A, B, and C. Objective of this study was to determine Candida albicans genotypes and antifungal susceptibility in candidiasis patients using PCR.
Methods: HIV-positive vaginal and oropharyngeal swabs yielded 126 Candida albicans isolates. Germ tube development, chlamydospore formation, CHROM agar color, sugar fermentation, and auxanographic plate technique with sugar discs identified all C. albicans isolates phenotypically. E-test tested antifungal susceptibility. Genotyping was done using PCR. The Phenol: Chloroform method extracted genomic DNA from all C. albicans isolates. The primer pairs and sequence encompassed the 25Sr DNA transposable intron. 5'-ATA AGG GAA GTC GGC AAA GAT CCG TAA-3' and CA-INT-R (reverse): 5'-CCT TGG CTG TGG TTT CGC TAG ATA GTA GAT-3'.
Results: Out of all the 126 profiles, PCR examination of the 25S rDNA transposable group I intron indicated 68.3% genotype A, 10.3% genotype B, and 21.4% genotype C isolates. Genotype A had 16.3% fluconazole resistance, genotype B 7.7%, and genotype C 3.7%. Genotype A strains were resistant to caspofungin, amphotericin B, flucytosine, and voriconazole at 3.5%, 5.8%, 8.1%, and 8.2%. While genotype B and C strains were sensitive.
Conclusions: C. albicans genotyping advances drug resistance research. C. albicans molecular typing helps design infection control methods by studying its epidemiology and pathophysiology.
Metrics
References
Rajeswari MR, Kalyani M, Hanumanthappa AR, Vijayaraghavan. R, Lava R. Detection of virulence factors in Candida isolated from different clinical specimens. IJBPAS. 2018;7(3):378-90. DOI: https://doi.org/10.31032/IJBPAS/2018/7.3.4397
Binesh LY, Kalyani M. Candida tropicalis and its antifungal susceptibility pattern. Journal of Clinical and Diagnostic Research. 2015;9(7):DC14-DC16.
Kaur R, Dhakad MS, Goyal R, Kumar R. Emergence of non-albicans Candida species and antifungal resistance in intensive care unit patients. Asian Pac J Trop Biomed. 2016;6(5):455-60. DOI: https://doi.org/10.1016/j.apjtb.2015.12.019
Kumarri S, Hanumanthappa AR, Rajeswari MR, Vishwanath G. Species distribution and antifungal susceptibility pattern of Candida isolated from various clinical samples obtained in a tertiary care hospital in Southern India. Journal of Pure and Applied Microbiology. 2015;9(1):637-42.
Mokaddas EM, Sweih A, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year. Study Journal of Medical Microbiology. 2007;56:255-9. DOI: https://doi.org/10.1099/jmm.0.46817-0
Girish Kumar CP, Hanafy AM, Katsu M, Mikami Y, Menon T. Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India. Mycopathologia. 2006;161:153-9. DOI: https://doi.org/10.1007/s11046-005-9210-6
Zhu X, Dong N, Wang Q, Cheng B, Zhu L, Tao J, et al. Genotyping and antifungal susceptibility of Candida albicans clinical isolates from Yangzhou region in China. Afr. J. Microbiol. Res. 2011;5(25):4406-10. DOI: https://doi.org/10.5897/AJMR11.602
McManus BA, and Coleman DC. Molecular epidemiology, phylogeny and evolution of Candida albicans.Infection, Genetics and Evolution. 2014;21:166-78. DOI: https://doi.org/10.1016/j.meegid.2013.11.008
Jain P, Khan ZK, Bhattacharya E, Ranade SA. Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and –sensitive strains of Candida albicans.Diagnostic Diagn Microbiol Infect Dis. 2001;41(3):113-9. DOI: https://doi.org/10.1016/S0732-8893(01)00292-9
McCullough MJ,Clemons KV, Stevensw DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol. 1999;37(2):417-21. DOI: https://doi.org/10.1128/JCM.37.2.417-421.1999
Bii CC, Kangogo MC, Revathi G, Wanyoike MW. Genotypes of Candida albicans from clinical sources in Nairobi Kenya. African Journal of Microbiology Research. 2009;3(9):475-7.
Mohammed S, Shatayeh A, Jamous MR, Nihad H, Alothman A, Moatasem H, et al. Genotyping and antifungal susceptibility of Candida albicans strainsfrom patients with vulvovaginal and cutaeneous candidiasis in Palestine. African Journal of Microbiology. 2015; 9(13):952-9. DOI: https://doi.org/10.5897/AJMR2014.7350